D epartment of Obstetrics & Gynecology, Central Michigan University School of Medicine, Saginaw, MI, USA.
Central Michigan University School of Medicine, Saginaw, MI, USA.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9320-9324. doi: 10.1080/14767058.2022.2030306. Epub 2022 Jan 24.
The aim of this study was to evaluate specific risk factors and their impact on hospital readmission risk following delivery in pregnancies affected by the hypertensive disease of pregnancy (HDP).
We performed a 10-year case-control study for patients who delivered at our institution and whose antenatal courses were complicated by HDP. The primary outcome was the identification of specific patient factors contributing to readmission. HDP pregnancies experiencing readmission for HDP signs and/or symptoms were used as the cases, with HDP pregnancies not experiencing readmission randomly selected as controls. Maternal age, gestational age at delivery, gravidity, parity, and mode of delivery (vaginal including operative, or cesarean) were recorded. Mean systolic and diastolic blood pressures were calculated over the 24 h preceding discharge. The most recent laboratory values preceding discharge for serum creatinine, lactate dehydrogenase, aspartate aminotransferase, alanine transaminase, and platelets were also recorded. The presence or absence of prescribed antihypertensive medication was recorded for initial hospitalization. Postpartum readmission was defined as within 30 days of delivery. Exclusion criteria involved readmission for non-HDP cause and maternal age less than 17 at delivery.
Within the study timeframe, 3601 patients with pregnancies complicated with HDP were identified. Of these, 34 patients were readmitted within 30 days postpartum for signs and/or symptoms of HDP after exclusion criteria were applied A cohort of 50 controls were used for comparison for a total of 84 participants. A diagnosis of pre-eclampsia was significantly associated with readmission (=.004) when compared to other HDP diagnoses. Demonstration of severe disease features also was associated significantly ( < 0.001) with readmission. Parity greater than or equal to three also was associated with readmission ( = 0.019). Notably, age, BMI, delivery mode, blood pressure preceding discharge, length of hospital stay, and being discharged with antihypertensive medication were not significantly associated with readmission.
This study suggests that readmission overall for the hypertensive disease of pregnancy is rare, but that patient variables of increasing parity and presence of severe features were associated with postpartum readmission. Knowledge of these variables may assist physicians in the identification of HDP patients who are at higher risk for readmission.
本研究旨在评估妊娠合并高血压疾病(HDP)患者分娩后发生再入院风险的特定危险因素及其影响。
我们对在我院分娩且产前合并 HDP 的患者进行了一项为期 10 年的病例对照研究。主要结局是确定导致再入院的特定患者因素。将因 HDP 体征和/或症状再次入院的 HDP 妊娠作为病例,随机选择未再次入院的 HDP 妊娠作为对照。记录产妇年龄、分娩时的孕周、孕次、产次和分娩方式(阴道分娩包括手术分娩和剖宫产)。计算出院前 24 小时的平均收缩压和舒张压。还记录了出院前最近一次的血清肌酐、乳酸脱氢酶、天门冬氨酸氨基转移酶、丙氨酸氨基转移酶和血小板的实验室值。记录初始住院时是否开具降压药物。产后 30 天内的再入院定义为再入院。排除标准包括因非 HDP 原因再入院和分娩时年龄小于 17 岁。
在研究时间段内,共确定了 3601 例合并 HDP 的妊娠患者。排除排除标准后,有 34 例患者因 HDP 体征和/或症状在产后 30 天内再次入院。共纳入 84 例患者,其中 34 例为病例组,50 例为对照组。与其他 HDP 诊断相比,子痫前期的诊断与再入院显著相关(=0.004)。严重疾病特征的表现也与再入院显著相关( < 0.001)。产次大于或等于 3 次也与再入院相关(=0.019)。值得注意的是,年龄、BMI、分娩方式、出院前血压、住院时间和出院时开具降压药物与再入院无显著相关性。
本研究表明,妊娠合并高血压疾病的总体再入院率较低,但患者变量中产次增加和存在严重特征与产后再入院相关。了解这些变量可能有助于医生识别再入院风险较高的 HDP 患者。